Efficacy and Safety Study of Lomustine/Temozolomide Combination Therapy vs. Standard Therapy for Glioblastoma Patients
NCT01149109
·
clinicaltrials.gov ↗
PHASE3
Phase
COMPLETED
Status
141
Enrollment
OTHER
Sponsor class
Conditions
Glioblastoma
Interventions
DRUG:
Temozolomide and lomustine
DRUG:
Temozolomide
Sponsor
University Hospital, Bonn